These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Propafenone--a new generation anti-arrhythmia agent]. Fischer M Med Klin; 1980 Jan; 75(1):39-41. PubMed ID: 6988688 [No Abstract] [Full Text] [Related]
24. [Case Report; A case of cibenzoline abuse was diagnosed by its loading]. Morishita K; Toyoshima T; Sano N; Harada H; Osawa M; Watanabe T; Handa M; Ozawa Y; Matsunaga H Nihon Naika Gakkai Zasshi; 2015 Feb; 104(2):302-4. PubMed ID: 26571711 [No Abstract] [Full Text] [Related]
25. Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes. Ingelfinger JR N Engl J Med; 2011 Mar; 364(10):970-1. PubMed ID: 21388316 [No Abstract] [Full Text] [Related]
29. [Arrhythmogenic effect of anti-arrhythmia drugs: incidence, possible mechanisms and therapeutic tactics]. Abdalla A; Mazur NA; Shestakova NV; Sumarokov AB Kardiologiia; 1990 Jan; 30(1):95-100. PubMed ID: 2186189 [No Abstract] [Full Text] [Related]
30. [Treatment of cardiac rhythm disorders with pulsnorm]. Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL Klin Med (Mosk); 1975 Jul; 53(7):57-61. PubMed ID: 1206994 [No Abstract] [Full Text] [Related]
31. [Hypoglycemia due to cibenzoline: role of hyperinsulinism]. Yazbeck R; Tauveron I; Hors S; Hillaire-Buys D; Blayac JP; Thieblot P Presse Med; 1999 May 22-29; 28(19):1017-8. PubMed ID: 10379350 [No Abstract] [Full Text] [Related]
32. Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias. Reiffel JA J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):333-9. PubMed ID: 11907635 [No Abstract] [Full Text] [Related]
33. [Antazolin(Antistina) in treatment of supraventricular tachycardia]. Mortensen E; Andersen M Ugeskr Laeger; 1974 Jun; 136(25):1393-4. PubMed ID: 4841115 [No Abstract] [Full Text] [Related]
35. A clinical study of intravenous cibenzoline in selected patients with recent-onset atrial tachyarrhythmia. Andrivet P; Mach V; Gnoc CV Chest; 1993 May; 103(5):1515-9. PubMed ID: 8486036 [TBL] [Abstract][Full Text] [Related]
36. Single infusion of intravenous cibenzoline in the treatment of supraventricular tachyarrhythmias following heart surgery. A double-blind placebo-controlled parallel study. Ollitrault J; Quilliet L; Scheck F; Lelong B; Richard A; Jarry G; Guize L Eur Heart J; 1994 Sep; 15(9):1274-8. PubMed ID: 7982430 [TBL] [Abstract][Full Text] [Related]
37. [Cardiogenic shock and major intra-ventricular block during treatment with cibenzoline]. Bourrier P; Chennebault JM; Harry P; Broudin S; Selenou M; Alquier P Therapie; 1987; 42(6):561-2. PubMed ID: 3441901 [No Abstract] [Full Text] [Related]
38. [Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia]. Hoffmann E; Bach P; Haberl R; Mattke S; Steinbeck G Z Kardiol; 1992 Jul; 81(7):378-84. PubMed ID: 1509795 [TBL] [Abstract][Full Text] [Related]
39. [Hypoglycemia caused by overdose of a new anti-arrhythmia agent: cibenzoline. 3 cases]. Lefort G; Haissaguerre M; Floro J; Beauffigeau P; Warin JF; Latapie JL Presse Med; 1988 Apr; 17(14):687-91. PubMed ID: 2966953 [TBL] [Abstract][Full Text] [Related]